Frontal nasal prominence expression driven by Tcfap2a relies on a conserved binding site for STAT proteins

Developmental Dynamics

Volumn 235, Issue 5, 2006, Pages 1358-1370

  Donner, Amy L ^a,c   Williams, Trevor ^a,b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Frontal nasal process; Limb bud; Sox6; STAT1; Tcfap2a

Indexed keywords

BETA GALACTOSIDASE; STAT PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CHORDATA; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYO; ENHANCER REGION; EVOLUTION; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC RESOURCE; INTRON; INVERTEBRATE; LIMB BUD; LIMB DEVELOPMENT; LIMB MALFORMATION; MESENCHYME; MOUSE; MULTIGENE FAMILY; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TCFAP2A GENE; TRANSGENE; TRANSGENIC MOUSE; VERTEBRATE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHICK EMBRYO; CONSERVED SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; NASAL BONE; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR AP-2;

CHORDATA; INVERTEBRATA; MUS MUSCULUS; VERTEBRATA;

EID: 33744912750     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.20722     Document Type: Article

References (92)

1. Abzhanov A, Tabin CJ. 2004. Shh and Fgf8 act synergistically to drive cartilage outgrowth during cranial development. Dev Biol 273:134-148.
2. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
3. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. 2004. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
4. Andrews NC, Faller DV. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
5. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T. 2002. Transcription factor AP-2γ is essential in the extra-embryonic lineages for early postimplantation development. Development 129:2733-2747.
6. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
7. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98:6698-6703.
8. Brewer S, Feng W, Huang J, Sullivan S, Williams T. 2004. Wnt1-Cre mediated deletion of AP-2α causes multiple neural crest related defects. Dev Biol 267:135-152.
9. Chen L, Deng CX. 2005. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci 10:1961-1976.
10. Chen L, Li D, Li C, Engel A, Deng CX. 2003. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33:169-178.
11. Cobb J, Duboule D. 2005. Comparative analysis of genes downstream of the Hoxd cluster in developing digits and external genitalia. Development 132:3055-3067.
12. Cordero D, Marcucio R, Hu D, Gaffield W, Tapadia M, Helms JA. 2004. Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes. J Clin Invest 114:485-494.
13. Davies AF, Mirza G, Flinter F, Ragoussis J. 1999a. An interstitial deletion of 6p24-p25 proximal to the FKHL7 locus and including AP-2α that affects anterior eye chamber development. J of Med Genet 36:708-710.
14. Davies AF, Mirza G, Sekhon G, Turnpenny P, Leroy F, Speleman F, Law C, van Regemorter N, Vamos E, Flinter F, Ragoussis J. 1999b. Delineation of two distinct 6p deletion syndromes. Hum Genet 104:64-72.
15. Davies SJ, Wise C, Venkatesh B, Mirza G, Jefferson A, Volpi EV, Ragoussis J. 2004. Mapping of three translocation breakpoints associated with orofacial clefting within 6p24 and identification of new transcripts within the region. Cytogenet Genome Res 105:47-53.
16. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C. 2000. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127:483-492.
17. Duncan SA, Zhong Z, Wen Z, Darnell JE, Jr. 1997. STAT signaling is active during early mammalian development. Dev Dyn 208:190-198.
18. Eames BF, Helms JA. 2004. Conserved molecular program regulating cranial and appendicular skeletogenesis. Dev Dyn 231:4-13.
19. Eames BF, Sharpe PT, Helms JA. 2004. Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev Biol 274:188-200.
20. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. 2002. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793.
21. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. 2004. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 101:12555-12560.
22. Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C. 2001. A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci U S A 98:3855-3860.
23. Hamburger V, Hamilton HL. 1951. A series of normal stages in the development of the chick embryo. J Morphol 88:49-92.
24. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. 2000. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 19:3309-3320.
25. Helms JA, Cordero D, Tapadia MD. 2005. New insights into craniofacial morphogenesis. Development 132:851-861.
26. Hilger-Eversheim K, Moser M, Schorle H, Buettner R. 2000. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260:1-12.
27. Holzschuh J, Barrallo-Gimeno A, Ettl AK, Durr K, Knapik EW, Driever W. 2003. Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. Development 130:5741-5754.
28. Hu D, Marcucio RS, Helms JA. 2003. A zone of frontonasal ectoderm regulates patterning and growth in the face. Development 130:1749-1758.
29. Iwata T, Li CL, Deng CX, Francomano CA. 2001. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum Mol Genet 10:1255-1264.
30. Kamachi Y, Uchikawa M, Kondoh H. 2000. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16:182-187.
31. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H. 2003. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979-1991.
32. Klonisch T, Fowler PA, Hombach-Klonisch S. 2004. Molecular and genetic regulation of testis descent and external genitalia development. Dev Biol 270:1-18.
33. Knight RD, Nair S, Nelson SS, Afshar A, Javidan Y, Geisler R, Rauch G-J, Schilling TF. 2003. lockjaw encodes a zebrafish tfap2a required for early neural crest development. Development 130:5755-5768.
34. Knight RD, Javidan Y, Zhang T, Nelson S, Schilling TF. 2005. AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo. Development 132:3127-3138.
35. Lefebvre V, Li P, de Crombrugghe B. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. Embo J 17:5718-5733.
36. L'Hote CG, Knowles MA. 2005. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304:417-431.
37. Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX. 1999. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8:35-44.
38. Luo T, Lee YH, Saint-Jeannet JP, Sargent TD. 2003. Induction of neural crest in Xenopus by transcription factor AP2α. Proc Natl Acad Sci USA 100:532-537.
39. Lüscher B, Mitchell PJ, Williams T, Tjian R. 1989. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 3:1507-1517.
40. Mani A, Radhakrishnan J, Farhi A, Carew KS, Warnes CA, Nelson-Williams C, Day RW, Pober B, State MW, Lifton RP. 2005. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci USA 102:2975-2979.
41. Mariani FV, Martin GR. 2003. Deciphering skeletal patterning: clues from the limb. Nature 423:319-325.
42. Mertin S, McDowall SG, Harley VR. 1999. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res 27:1359-1364.
43. Meulemans D, Bronner-Fraser M. 2002. Amphioxus and lamprey AP-2 genes: implications for neural crest evolution and migration patterns. Development 129:4953-4962.
44. Meulemans D, Bronner-Fraser M. 2004. Gene-regulatory interactions in neural crest evolution and development. Dev Cell 7:291-299.
45. Mitchell PJ, Timmons PM, Hebert JM, Rigby PWJ, Tjian R. 1991. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 5:105-119.
46. Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B. 2003. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci U S A 100:9360-9365.
47. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R, Fassler R. 1997. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev 11:1938-1948.
48. Murphy EC, Zhurkin VB, Louis JM, Cornilescu G, Clore GM. 2001. Structural basis for SRY-dependent 46-X,Y sex reversal: modulation of DNA bending by a naturally occurring point mutation. J Mol Biol 312:481-499.
49. Nagy A, Gertsenstein M, Vintersten K, Behringer R. 2003. Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
50. Nakashima K, de Crombrugghe B. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19:458-466.
51. Nelson DK, Williams T. 2004. Frontonasal process-specific disruption of AP-2α results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects. Dev Biol 267:72-92.
52. Niswander L. 2003. Pattern formation: old models out on a limb. Nat Rev Genet 4:133-143.
53. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T. 1998. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc Natl Acad Sci USA 95:13714-13719.
54. O'Brien EK, d'Alencon C, Bonde G, Li W, Schoenebeck J, Allende ML, Gelb BD, Yelon D, Eisen JS, Cornell RA. 2004. Transcription factor AP-2α is necessary for development of embryonic melanophores, autonomic neurons and pharyngeal skeleton in zebrafish. Dev Biol 265:246-261.
55. Ornitz DM. 2005. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16:205-213.
56. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465.
57. Pfeifer D, Poulat F, Holinski-Feder E, Kooy F, Scherer G. 2000. The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics 63:108-116.
58. Philipp J, Mitchell PJ, Malipiero U, Fontana A. 1994. Cell type-specific regulation of expression of transcription factor AP-2 in neuroectodermal cells. Dev Biol 165:602-614.
59. Quandt K, Frech K, Karas H, Wingender E, Werner T. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
60. Richman JM, Lee SH. 2003. About face: signals and genes controlling jaw patterning and identity in vertebrates. Bioessays 25:554-568.
61. Sahar DE, Longaker MT, Quarto N. 2005. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev Biol 280:344-361.
62. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366.
63. Sahni M, Raz R, Coffin JD, Levy D, Basilico C. 2001. STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128:2119-2129.
64. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD. 2000. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 25:42-46.
65. Schepers GE, Bullejos M, Hosking BM, Koopman P. 2000. Cloning and characterisation of the Sry-related transcription factor gene Sox8. Nucleic Acids Res 28:1473-1480.
66. Schmidt K, Schinke T, Haberland M, Priemel M, Schilling AF, Mueldner C, Rueger JM, Sock E, Wegner M, Amling M. 2005. The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J Cell Biol 168:899-910.
67. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. 1996. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235-238.
68. Schultz RE, Cooper ME, Daack-Hirsch S, Shi M, Nepomucena B, Graf KA, O'Brien EK, O'Brien SE, Marazita ML, Murray JC. 2004. Targeted scan of fifteen regions for nonsyndromic cleft lip and palate in Filipino families. Am J Med Genet 125A:17-22.
69. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, Shinomiya K, Nifuji A, Noda M. 2000. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275:10738-10744.
70. Shashikant CS, Bieberich CJ, Belting HG, Wang JC, Borbely MA, Ruddle FH. 1995. Regulation of Hoxc-8 during mouse embryonic development: identification and characterization of critical elements involved in early neural tube expression. Development 121:4339-4347.
71. Shen H, Wilkie T, Ashique AM, Narvey M, Zerucha T, Savino E, Williams T, Richman JM. 1997. Chicken transcription factor AP-2: cloning, expression and its role in outgrowth of facial promineneces and limb buds. Dev Biol. 188:248-266.
72. Smits P, Li P, Mandel J, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B, Lefebvre V. 2001. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290.
73. Sock E, Rettig SD, Enderich J, Bosl MR, Tamm ER, Wegner M. 2004. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol 24:6635-6644.
74. Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA, Fu XY. 1997. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.
75. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801-3804.
76. Thyagarajan T, Totey S, Danton MJ, Kulkarni AB. 2003. Genetically altered mouse models: the good, the bad, and the ugly. Crit Rev Oral Biol Med 14:154-174.
77. Tickle C. 2003. Patterning systems: from one end of the limb to the other. Dev Cell 4:449-458.
78. Topping A, Harris P, Moss AL. 2002. The 6p deletion syndrome: a new orofacial clefting syndrome and its implications for antenatal screening. Br J Plast Surg 55:68-72.
79. van Houte LP, Chuprina VP, van der Wetering M, Boelens R, Kaptein R, Clevers H. 1995. Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4. J Biol Chem 270:30516-30524.
80. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, Richtsmeier JT, Leszl JM, Hill CA, Yu K, Ornitz DM, Elisseeff J, Huso DL, Jabs EW. 2005. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132:3537-3548.
81. Wegner M. 1999. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27:1409-1420.
82. Werling U, Schorle H. 2002. Transcription factor gene AP-2γ essential for early murine development. Mol Cell Biol 22:3149-3156.
83. Werner MH, Huth JR, Gronenborn AM, Clore GM. 1995. Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81:705-714.
84. Wilkie AO, Morriss-Kay GM. 2001. Genetics of craniofacial development and malformation. Nat Rev Genet 2:458-468.
85. Williams T, Admon A, Lüscher B, Tjian R. 1988. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2:1557-1569.
86. Wilson M, Koopman P. 2002. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12:441-446.
87. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD, Hurley MM. 2004. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279:27743-27752.
88. Yamada G, Satoh Y, Baskin LS, Cunha GR. 2003. Cellular and molecular mechanisms of development of the external genitalia. Differentiation 71:445-460.
89. Yamaguchi TP, Bradley A, McMahon AP, Jones S. 1999. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211-1223.
90. Zelzer E, Olsen BR. 2003. The genetic basis for skeletal diseases. Nature 423:343-348.
91. Zhang J, Williams T. 2003. Identification and Regulation of Tissue-Specific cis-acting Elements Associated with the Human AP-2α Gene. Dev Dyn 228:194-207.
92. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, Williams T. 1996. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381:238-241.